25 million Kenyans in dire need of COVID-19 vaccine to curb virus spread

COVID-19 vaccine. [Photo: European Pharmaceutical Vaccine]

Kenya recorded 184 more COVID-19 cases on Thursday bringing the country’s total cases to 38,713.

Health CS Mutahi Kagwe in a statement to newsrooms said that  4,700 samples were tested in the last 24 hours bringing the total number of samples tested so far to 552,646.

Of the positive cases, 170 are Kenyans while 14 are foreigners.

110 are male and 74 are female with the youngest being a two-year-old child and the oldest was 88 years.

Some 115 patients were discharged; 67 from home-based care programme and 48 from hospitals around the country bringing the total number of recoveries to 25,023.

On a sad note, 7 patients succumbed to the disease bringing the total number of deaths to 718.

In the new cases recorded, Nairobi led with 58 cases, Mombasa 22, Kisumu 20, Nakuru 13, Kericho 13, Trans Nzoia 8, Laikipia 7, Machakos 7, Uasin Gishu 6, Narok 6, Kisii 6, Kiambu 4, Kwale 4, Homabay 3, Bomet 2, Embu 2, whilw West Pokot, Makueni, Nandi and Siaya had a case each.

The new cases come amid reports that at an estimated 25 million Kenyans need to develop immunity against COVID-19 to completely stop its spread.

Scientists now say that to achieve this goal, it will be paramount for this demographic to get vaccines against the virus.

According to scientists, vaccines will be the easiest model to achieve this adding that natural immunity could fatally kill over 50% of the population before suppressing the spread of coronavirus.

“There is little evidence to suggest that the spread of SARS-CoV-2 might stop naturally before at least 50 per cent of the population has become immune,” a study published in Nature says.